Biosimilar switching in inflammatory bowel disease: from evidence to clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilar switching in inflammatory bowel disease: from evidence to clinical practice

Published:2020-09-29 Issue:10 Volume:16 Page:1019-1028
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Solitano Virginia¹,D’Amico Ferdinando¹²,Fiorino Gionata¹³,Peyrin-Biroulet Laurent²,Danese Silvio¹³^ORCID

Affiliation:

1. Department of Biomedical Sciences, Humanitas University, Milan, Italy

2. Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France

3. Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, IRCCS, Milan, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2021.1826311

Reference61 articles.

1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

2. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

3. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA;Pharmaceutics;2024-05-08

2. Effectiveness and safety of adalimumab biosimilar in patients with inflammatory bowel disease;Farmacia Hospitalaria;2024-04

3. Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway;Expert Opinion on Biological Therapy;2023-11

4. Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus;Journal of Clinical Medicine;2023-10-03

5. Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients;World Journal of Clinical Cases;2022-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3